Financial results: Avecho; Elixinol; Epsilon; Creso Pharma by Steve Jones May 2, 2023April 30, 2024 Biotech firm Avecho has told the Australian Securities Exchange (ASX) that it has no concerns over […]
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024